Latest Insider Transactions at Lixte Biotechnology Holdings, Inc. (LIXT)
This section provides a real-time view of insider transactions for Lixte Biotechnology Holdings, Inc. (LIXT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LIXTE BIOTECHNOLOGY HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 03
2023
|
Baan Bastiaan Jeroen Van Der President, CEO & Vice Chairman |
BUY
Open market or private purchase
|
Direct |
10,000
+47.62%
|
$20,000
$2.8 P/Share
|
Oct 03
2023
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
5,527
+21.65%
|
$11,054
$2.51 P/Share
|
Oct 02
2023
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
4,473
+18.68%
|
$8,946
$2.29 P/Share
|
Dec 30
2022
|
Baan Bastiaan Jeroen Van Der President, CEO & Vice Chairman |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$40,000
$4.9 P/Share
|
Dec 15
2022
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
15,000
+9.09%
|
$0
$0.51 P/Share
|
Dec 12
2022
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.9%
|
$0
$0.61 P/Share
|
Dec 09
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
16,112
+4.41%
|
$0
$0.62 P/Share
|
Nov 22
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
2,484
+2.38%
|
$0
$0.56 P/Share
|
Nov 21
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
1,457
+1.44%
|
$0
$0.56 P/Share
|
Nov 21
2022
|
Regina Brown Director |
BUY
Open market or private purchase
|
Direct |
5,000
+34.28%
|
$0
$0.58 P/Share
|
Nov 18
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
16,207
+5.44%
|
$0
$0.56 P/Share
|
Nov 17
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
4,852
+5.59%
|
$0
$0.54 P/Share
|
Nov 14
2022
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
52,500
+29.58%
|
$0
$0.53 P/Share
|
Dec 17
2021
|
Eric Forman Vice President and COO |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,333,333
-97.19%
|
-
|
Apr 22
2021
|
Eric Forman Vice President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+30.16%
|
$0
$0.9 P/Share
|
Apr 22
2021
|
Philip F Palmedo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+41.2%
|
$0
$0.72 P/Share
|
Apr 22
2021
|
Stephen J. Forman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,334
+36.44%
|
$0
$0.96 P/Share
|
Jan 04
2021
|
Eric Forman Vice President and COO |
BUY
Bona fide gift
|
Direct |
2,364
+9.73%
|
-
|
Dec 30
2020
|
Eric Forman Vice President and COO |
BUY
Bona fide gift
|
Direct |
2,900
+12.91%
|
-
|
Nov 30
2020
|
Hung Tak Ho > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
42,105
+3.88%
|
$168,420
$4.75 P/Share
|
Nov 30
2020
|
Gil Schwartzberg Director |
BUY
Open market or private purchase
|
Direct |
105,264
+29.82%
|
$421,056
$4.75 P/Share
|
Nov 30
2020
|
Yun Yen Director |
BUY
Open market or private purchase
|
Indirect |
52,632
+50.0%
|
$210,528
$4.75 P/Share
|
Nov 30
2020
|
Stephen J. Forman Director |
BUY
Open market or private purchase
|
Indirect |
21,053
+35.82%
|
$84,212
$4.75 P/Share
|
Nov 30
2020
|
Philip F Palmedo Director |
BUY
Open market or private purchase
|
Direct |
21,053
+39.64%
|
$84,212
$4.75 P/Share
|
Nov 30
2020
|
Robert Greenberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
52,632
+5.03%
|
$210,528
$4.75 P/Share
|
Nov 30
2020
|
John S Kovach President and CEO |
BUY
Open market or private purchase
|
Indirect |
21,100
+1.35%
|
$84,400
$4.75 P/Share
|